| Host: |
Rabbit |
| Applications: |
WB |
| Reactivity: |
Human/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Myc target protein 1 (114-164) is suitable for use in Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:1000-2000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
MYCT1 |
| Gene ID: |
80177 |
| Uniprot ID: |
MYCT1_HUMAN |
| Immunogen Region: |
114-164 |
| Specificity: |
This antibody detects endogenous levels of human MYCT1 |
| Immunogen: |
Synthesized peptide derived from human MYCT1 AA range: 114-164 |
| Function | May regulate certain MYC target genes, MYC seems to be a direct upstream transcriptional activator. Does not seem to significantly affect growth cell capacity. Overexpression seems to mediate many of the known phenotypic features associated with MYC, including promotion of apoptosis, alteration of morphology, enhancement of anchorage-independent growth, tumorigenic conversion, promotion of genomic instability, and inhibition of hematopoietic differentiation. |
| Protein Name | Myc Target Protein 1Myc Target In Myeloid Cells Protein 1 |
| Cellular Localisation | NucleusExpressed In Nuclei Of Hepatocellular Carcinoma Cell Line Bel-7402 Cells |
| Alternative Antibody Names | Anti-Myc Target Protein 1 antibodyAnti-Myc Target In Myeloid Cells Protein 1 antibodyAnti-MYCT1 antibodyAnti-MTLC antibodyAnti-MTMC1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
